b'SIU ACADEMY: BRINGING EDUCATION ONLINEBENCH-TO-BEDSIDE MEETINGSIU B2B Uro-Oncology: GU Cancers Triad Virtual MeetingScientific Programme Committee: Peter Black (Canada), Christopher Evans (United States), Peter Hammerer (Germany), Simon Tanguay (Canada)Presenting Sponsors: Contributing Sponsor:Bristol Myers Squibb F. Hoffmann-La Roche Ltd.Merck & Co. With the support of:Merck KGaA, Darmstadt, GermanyPfizer Alliance World Bladder Cancer Patient CoalitionThe B2B Uro-Oncology: GU Cancers Triad session covered topics on selecting appropriate Virtual Meeting was organized by SIU and wastreatment for renal cell carcinoma (RCC), held online on November 7 and 8, 2020. Thisupcoming practice-changing advancements, event brought together more than 2,400 livehow to adapt RCC care to changing times, and attendees from over 90 countries during thehow to address immune-related adverse events. two-day programme. All content was madeIn addition, there was a case- based discussion available, on-demand, following the event and question-and-answer session.and garnered views from close to 2,500 additional participants. The session on prostate cancer (PCa) tookplace on the morning of Sunday, November 8. The session on bladder cancer (BCa) took placeDr Christopher Evans (United States) andon the morning of Saturday, November 7, andDr Peter Hammerer (Germany) co-chaired the was chaired by Dr Peter Black (Canada). Thissession, which covered research topics andsession covered practice-changing advancesthe identification of innovative treatmentson the horizon for BCa, advances specific tofor localized PCa, locally advanced PCa,nonmuscle-invasive BCa (NMIBC) and muscle- and metastatic PCa. There were also threeinvasive disease (MIBC), and systemic therapycase-based discussions and a question-and-for advanced disease. The faculty also providedanswer session.some tips on how to manage immune-related adverse events. The event was accredited by the European Accreditation Council for Continuing Medical The session on kidney cancer took placeEducation (EACCME). Registrants who following the bladder cancer programme, onattended the live broadcasts on November 7 the morning of Saturday, November 7. It wasand 8 were eligible to claim up to 6 European chaired by Dr Simon Tanguay (Canada). ThisCME credits (ECMECs).S I U - U R O L O G Y. O R G 25'